Johanna Mylet Poseida Therapeutics, Inc. (PSTX) insider trading activity

Johanna Mylet is Chief Financial Officer of Poseida Therapeutics, Inc.. Currently has a direct ownership of 0 shares of PSTX, which is worth approximately $0. The most recent transaction as insider was on Jan 08, 2025, when has been sold 254,852 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

Johanna Mylet Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 08 2025	SELL Disposition due to a tender of shares in a change of control transaction	-	254,852 Reduced 100.0%	0 Common Stock
Mar 01 2024	SELL Payment of exercise price or tax liability	$74,715 $4.13 p/Share	18,091 Reduced 6.84%	246,283 Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	-	80,743 Added 23.4%	264,374 Common Stock
Mar 01 2023	SELL Payment of exercise price or tax liability	$23,128 $5.35 p/Share	4,323 Reduced 2.38%	177,631 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	92,772 Added 33.77%	181,954 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	50,000 Added 37.25%	84,231 Common Stock
Dec 21 2021	BUY Exercise of conversion of derivative security	$8,860 $1.55 p/Share	5,716 Added 14.31%	34,231 Common Stock
Jan 15 2021	BUY Exercise of conversion of derivative security	$1,418 $0.3 p/Share	4,728 Added 14.99%	26,813 Common Stock

Johanna Mylet

Chief Financial Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PSTX shares.

Notify only if

Value

Insider Trading

Get notified when an Poseida Therapeutics, Inc. insider buys or sells PSTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Poseida Therapeutics, Inc.

Track Activities on PSTX

Account